AstraZeneca and Sanofi Expand R&D in China Amidst Pharmaceutical Industry Growth

AstraZeneca and Sanofi have expanded their R&D operations in China, a highly sought-after market for the global pharmaceutical industry. AstraZeneca has established a new research center in Shanghai, while Sanofi has opened a new R&D facility in Beijing. These moves aim to tap into China's large and growing pharmaceutical market, as well as its highly skilled workforce. The expansion is expected to drive innovation and create new opportunities for both companies.